Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael R Jordan

Showing results (91-100 of 103) with videos related to

Pageof 11
Sort By:
Aiche Journal. American Institute of Chemical Engineers|September 19, 2019
The Effect of Divalent Cations on the Thermostability of Type II Polyketide Synthase Acyl Carrier ProteinsMarco Rivas, Valentine C Courouble, Miranda C Baker, et al.
The Lancet. HIV|November 28, 2017
Cost-effectiveness of public-health policy options in the presence of pretreatment NNRTI drug resistance in sub-Saharan Africa: a modelling studyAndrew N Phillips, Valentina Cambiano, Fumiyo Nakagawa, et al.
Frontiers in Public Health|January 2, 2026
Transdisciplinary training to address challenges in genomic epidemiology of infectious diseasesSamuel L Hong, Marie Stockman, Jorge Ricardo Nova Blanco, et al.
The Lancet. HIV|June 27, 2025
Evaluation of antiretroviral regimen switching options in adults with HIV with sustained viral load non-suppression on dolutegravir, lamivudine, and tenofovir in eastern, central, southern, and western Africa: a modelling studyAndrew N Phillips, Loveleen Bansi-Matharu, Joep J van Oosterhout, et al.
The Lancet. Infectious Diseases|December 5, 2017
HIV-1 drug resistance before initiation or re-initiation of first-line antiretroviral therapy in low-income and middle-income countries: a systematic review and meta-regression analysisRavindra K Gupta, John Gregson, Neil Parkin, et al.
Plos One|December 31, 2015
HIV-1 Drug Resistance Mutations: Potential Applications for Point-of-Care Genotypic Resistance TestingSoo-Yon Rhee, Michael R Jordan, Elliot Raizes, et al.
The Lancet. Microbe|April 12, 2025
Hepatitis B virus resistance to nucleos(t)ide analogue therapy: WHO consultation on questions, challenges, and a roadmap for the fieldSheila F Lumley, Jolynne Mokaya, Tongai G Maponga, et al.
Plos Medicine|September 22, 2023
Recommendations on data sharing in HIV drug resistance researchSeth C Inzaule, Mark J Siedner, Susan J Little, et al.
The Journal of Infectious Diseases|May 21, 2013
Nucleoside reverse transcriptase inhibitor resistance mutations associated with first-line stavudine-containing antiretroviral therapy: programmatic implications for countries phasing out stavudineMichele W Tang, Soo-Yon Rhee, Silvia Bertagnolio, et al.
Plos Medicine|April 8, 2015
Geographic and temporal trends in the molecular epidemiology and genetic mechanisms of transmitted HIV-1 drug resistance: an individual-patient- and sequence-level meta-analysisSoo-Yon Rhee, Jose Luis Blanco, Michael R Jordan, et al.
Pageof 11

Showing results (91-100 of 103) with videos related to

Sort By:
Pageof 11
Aiche Journal. American Institute of Chemical Engineers|September 19, 2019
The Effect of Divalent Cations on the Thermostability of Type II Polyketide Synthase Acyl Carrier ProteinsMarco Rivas, Valentine C Courouble, Miranda C Baker, et al.
The Lancet. HIV|November 28, 2017
Cost-effectiveness of public-health policy options in the presence of pretreatment NNRTI drug resistance in sub-Saharan Africa: a modelling studyAndrew N Phillips, Valentina Cambiano, Fumiyo Nakagawa, et al.
Frontiers in Public Health|January 2, 2026
Transdisciplinary training to address challenges in genomic epidemiology of infectious diseasesSamuel L Hong, Marie Stockman, Jorge Ricardo Nova Blanco, et al.
The Lancet. HIV|June 27, 2025
Evaluation of antiretroviral regimen switching options in adults with HIV with sustained viral load non-suppression on dolutegravir, lamivudine, and tenofovir in eastern, central, southern, and western Africa: a modelling studyAndrew N Phillips, Loveleen Bansi-Matharu, Joep J van Oosterhout, et al.
The Lancet. Infectious Diseases|December 5, 2017
HIV-1 drug resistance before initiation or re-initiation of first-line antiretroviral therapy in low-income and middle-income countries: a systematic review and meta-regression analysisRavindra K Gupta, John Gregson, Neil Parkin, et al.
Plos One|December 31, 2015
HIV-1 Drug Resistance Mutations: Potential Applications for Point-of-Care Genotypic Resistance TestingSoo-Yon Rhee, Michael R Jordan, Elliot Raizes, et al.
The Lancet. Microbe|April 12, 2025
Hepatitis B virus resistance to nucleos(t)ide analogue therapy: WHO consultation on questions, challenges, and a roadmap for the fieldSheila F Lumley, Jolynne Mokaya, Tongai G Maponga, et al.
Plos Medicine|September 22, 2023
Recommendations on data sharing in HIV drug resistance researchSeth C Inzaule, Mark J Siedner, Susan J Little, et al.
The Journal of Infectious Diseases|May 21, 2013
Nucleoside reverse transcriptase inhibitor resistance mutations associated with first-line stavudine-containing antiretroviral therapy: programmatic implications for countries phasing out stavudineMichele W Tang, Soo-Yon Rhee, Silvia Bertagnolio, et al.
Plos Medicine|April 8, 2015
Geographic and temporal trends in the molecular epidemiology and genetic mechanisms of transmitted HIV-1 drug resistance: an individual-patient- and sequence-level meta-analysisSoo-Yon Rhee, Jose Luis Blanco, Michael R Jordan, et al.
Pageof 11